[1]齐金蕾，王黎君，周脉耕，等.1990-2013年中国男性前列腺癌疾病负担分析［J］.中华流行病学杂志，2016，37(6)：778-782.
QI JL，WANG LJ，ZHOU MG，et al.Disease burden of prostate cancer among men in China，from 1990 to 2013［J］.Chinese Journal of Epidemiology，2016，37(6)：778-782.
[2]YUAN F，WANG W.MicroRNA-802 suppresses breast cancer proliferation through downregulation of FoxM1［J］.Molecular Medicine Reports，2015，12(3)：4647-4651.
[3]ZHANG XY，MU JH，LIU LY，et al.Upregulation of miR-802 suppresses gastric cancer oncogenicity via targeting RAB23 expression［J］.Europen Review for Medical and Pharmacological Sciences，2017，21(18)：4071-4078.
[4]JIANG Y，HAN Y，SUN C，et al.Rab23 is overexpressed in human bladder cancer and promotes cancer cell proliferation and invasion［J］.Tumor Biology，2016，37(6)：8131-8138.
[5]LIU Y，ZENG C，BAO N，et al.Effect of Rab23 on the proliferation and apoptosis in breast cancer［J］.Oncology Reports，2015，34(4)：1835-1844.
[6]赵斌，李支尧，张志平，等.单纯化疗和化疗加生物免疫治疗对转移性前列腺癌的临床疗效及安全性比较［J］.中国临床研究，2016，29(4)：476-479.
ZHAO B，LI ZY，ZHANG ZP，et al.Clinical efficacy and safety of chemotherapy alone versus chemotherapy plus biological immunotherapy for treating metastatic prostate cancer［J］.Chinese Journal of Clinical Research，2016，29(4)：476-479.
[7]李海斌，敬培胜.前列腺癌患者根治术后病理Gleason评分升高预测因素研究［J］.第三军医大学学报，2016，38(24)：2656-2660.
LI HB，JING PS.Predictive factors of Gleason score upgrading in prostate cancer patients after radical prostatectomy［J］.Acta Academiae Medicinae Militaris Tertiae，2016，38(24)：2656-2660.
[8]黄幼生，解娜，张艺馨，等.胃癌组织microRNA表达谱检测及生物信息学分析［J］.临床与实验病理学杂志，2017，33(6)：5-9.
HUANG YS，XIE N，ZHANG YX，et al.Expression profile of microRNAs and bioinformatics analysis in human gastric cancer tissues［J］.Chinese Journal of Clinical and Experimental Pathology，2017，33(6)：5-9.
[9]彭永华，杨文飞，卢绍伟，等.miRNA在喉癌中作用机制的研究进展［J］.临床耳鼻咽喉头颈外科杂志，2017，31(14)：83-88.
PENG YH，YANG WF，LU SW，et al.Mechanism research progress of miRNA in laryngeal carcinoma［J］.Journal of Clinical Otorhinolarynglolgy Head and Neck Surgery，2017，31(14)：83-88.
[10]FU F，WAN X，WANG D，et al.MicroRNA-19a acts as a prognostic marker and promotes prostate cancer progression via inhibiting VPS37A expression［J］.Oncotarget，2018，9(2)：1931- 1943.
[11]AHERNE ST，O' NEILL F，MADDEN SF，et al.Abstract 1091：miR-125 family of miRNAs mediates prostate cancer cell proliferation and migration［J］.Cancer Research，2016，76(14)：1091.
[12]LUO B，KANG N，CHEN Y，et al.Oncogene miR-106a promotes proliferation and metastasis of prostate cancer cells by directly targeting PTEN in vivo and in vitro［J］.Minerva Medica，2017，109(1)：24-30.
[13]YANG Y，GUO JX，SHAO ZQ.miR-21 targets and inhibits tumor suppressor gene PTEN to promote prostate cancer cell proliferation and invasion：An experimental study［J］.Asian Pacific Journal of Tropical Medicine，2017，10(1)：87-91.
[14]WANG D，LU G，SHAO Y，et al.microRNA-802 inhibits epithelial-mesenchymal transition through targeting flotillin-2 in human prostate cancer［J］.Bioscience Reports，2017，37(2)：1-10.
[15]WANG M，DONG Q，WANG Y.Rab23 is overexpressed in human astrocytoma and promotes cell migration and invasion through regulation of Rac1［J］.Tumor Biology，2016，37(8)：1-7.
[16]QIANG J，YE M，LI T，et al.Rab23 promotes squamous cell carcinoma cell migration and invasion via integrin β1/Rac1 pathway［J］.Oncotarget，2016，7(5)：5342-5352.
[17]CHANG J，XU W，LIU G，et al.Downregulation of rab23 in prostate cancer inhibits tumor growth in vitro and in vivo［J］.Oncology Research，2017，25(2)：241-248.